InsiderTrades

Form 4 for WGS GeneDx Holdings Corp.

Accepted 2021-12-03 00:00:00 ET · period of report 2021-12-01 · accession 0001209191-21-067991 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
2021-12-03 2021-12-01 WGS Prentice Anthony Chief Product Off F - Tax $5.52 -2,885 5,293 -35% -$15.9K
2021-12-03 2021-12-01 WGS Prentice Anthony Chief Product Off A - Grant $6.05 +6,257 8,577 +270% +$37.9K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2021-12-01 F D 2,885 $5.52 5,293 D — — (F3) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.51 to $5.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
2 Common Class A Common Stock 2021-12-01 A A 6,257 $6.05 8,577 D — — (F1) The indicated shares were issued to Reporting Person as a stock bonus in connection with the elimination of Issuer's sabbatical leave program, in which all employees of Issuer hired on or before June 30, 2021 were provided an opportunity to receive a stock bonus in lieu of their continued eligibility to take sabbatical leave. The stock bonus was fully vested as of the date of issuance.